feed,title,long_url,short_url
Investors,How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month,https://www.investors.com/news/technology/cytk-stock-how-cytokinetics-overcame-two-big-setbacks-to-double-in-a-month/,https://da.gd/5aGWV
Investors,Dynatrace Plunges As Annual Recurring Revenue Edges By Views,https://www.investors.com/news/technology/dt-stock-dynatrace-stock-dynatrace-earnings-q42023/,https://da.gd/Z9Z2RX
Investors,AstraZeneca Downgraded On 'Underwhelming' Q4 Earnings,https://www.investors.com/news/technology/azn-stock-astrazeneca-earnings-q4-2023/,https://da.gd/tBmEi
